Human papillomavirus 16 load in normal and abnormal cervical scrapes: An indicator of CIN II/III and viral clearance

International Journal of Cancer

Volumn 98, Issue 4, 2002, Pages 590-595

  Van Duin, Mark ^a   Snijders, Peter J F ^a   Schrijnemakers, Henri F J ^a   Voorhorst, Feja J ^a   Rozendaal, Lawrence ^a   Nobbenhuis, Marielle A E ^a   Van Den Brule, Adriaan J C ^a   Verheijen, René H M ^a   Helmerhorst, Theo J ^b   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Abnormal cytology; CIN II III; HPV 16 load; Normal cytology; Viral clearance

Indexed keywords

ARTICLE; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS LOAD; WART VIRUS;

ADULT; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

EID: 0036533620     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10232     Document Type: Article

References (25)

1. Human papillomavirus is a necessary cause of invasive cancer worldwide
2. Screening for cervical cancer: Should we test for infection with high-risk HPV?
3. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia
4. Relation of human papillomavirus status to cervical lesions and consequences for cervical cancer screening: A prospective study
5. Epidemiology of cervical human papillomavirus infections
6. Detection of human papillomavirus infections and possible clinical implications
7. Type-specific human papillomavirus DNA in abnormal scrapes as a predictor of high-grade cervical intraepithelial neoplasia
8. Human papillomavirus type 16 DNA in cervical scrapes as predictor of high-grade cervical cancer
9. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic scrape report
10. Serial quantitation of HPV 16 in the scrapes of women with mild and moderate dyskaryosis
11. Human papillomavirus detection by hybrid capture and its possible clinical use
12. Human papillomavirus detection by the hybrid capture II assay: A reliable test to select women with normal cervical scrapes at risk for developing cervical lesions
13. Hybrid capture II-based human papillomavirus detection, a sensitive test to detect in routine high-grade cervical lesions: A preliminary study on 1518 women
14. Distribution of human papillomaviruses in women
15. Evaluation of the hybrid capture human papillomavirus deoxyribonucleic acid detection test
16. Viral load of human papillomavirus 16 as a determinant for development of cervical carcinoma in situ: A nested case-control study
17. PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears
18. High-risk human papillomavirus in women with normal cervical cytology prior to the development of abnormal cytology and colposcopy
19. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
20. Rapid human papillomavirus detection in cervical scrapes by combined general primer-mediated and type-specific polymerase chain reaction
21. A quantitative polymerase chain reaction-enzyme immunoassay for accurate measurements of human papillomavirus type 16 DNA levels in cervical scrapings
22. High-risk HPV testing in women with borderline and mild dyskaryosis: Long term follow-up data and clinical relevance
23. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal smear
24. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: A nested case-control study